Packages (Simulation)
Reagent Preparation
Image (I)
-
Results demonstration
Image (II)
-
Typical Standard Curve
Quality Guarantee
Instruction Manual
Certificate
Maybe you can also pay attention to our smart microplate reader
Mini Samples ELISA Kit for Asprosin (Asp)
- Product No.MEA332Hu
- Organism SpeciesHomo sapiens (Human) Same name, Different species.
- Sample Typeserum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
- Test MethodDouble-antibody Sandwich
- Assay Length3h
- Detection Range0.156-10ng/mL
- SensitivityThe minimum detectable dose of this kit is typically less than 0.058ng/mL.
- DownloadInstruction Manual
- UOM 48T96T 96T*5 96T*10 96T*100
- FOB
US$ 529
US$ 756
US$ 3402
US$ 6426
US$ 52920
For more details, please contact local distributors!
Specificity
This assay has high sensitivity and excellent specificity for detection of Mini Samples Asprosin (Asp).
No significant cross-reactivity or interference between Mini Samples Asprosin (Asp) and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Mini Samples Asprosin (Asp) and the recovery rates were calculated by comparing the measured value to the expected amount of Mini Samples Asprosin (Asp) in samples.
| Matrix | Recovery range (%) | Average(%) |
| serum(n=5) | 82-92 | 85 |
| EDTA plasma(n=5) | 88-103 | 93 |
| heparin plasma(n=5) | 86-98 | 91 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Mini Samples Asprosin (Asp) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Mini Samples Asprosin (Asp) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Mini Samples Asprosin (Asp) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
| Sample | 1:2 | 1:4 | 1:8 | 1:16 |
| serum(n=5) | 88-95% | 95-105% | 80-89% | 82-102% |
| EDTA plasma(n=5) | 99-105% | 94-101% | 78-99% | 79-99% |
| heparin plasma(n=5) | 94-105% | 80-90% | 85-101% | 90-97% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
| Reagents | Quantity | Reagents | Quantity |
| Pre-coated, ready to use 96-well strip plate | 1 | Plate sealer for 96 wells | 4 |
| Standard | 2 | Standard Diluent | 1×20mL |
| Detection Reagent A | 1×60µL | Assay Diluent A | 1×6mL |
| Detection Reagent B | 1×60µL | Assay Diluent B | 1×6mL |
| TMB Substrate | 1×4.5mL | Stop Solution | 1×3mL |
| Wash Buffer (30 × concentrate) | 1×10mL | Instruction manual | 1 |
Assay procedure summary
1. Prepare all reagents, samples and standards;
2. Add 25µL standard or sample to each well. Incubate 1 hour at 37°C;
3. Aspirate and add 25µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 25µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 25µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 20µL Stop Solution. Read at 450nm immediately.
GIVEAWAYS
INCREMENT SERVICES
| Magazine | Citations |
| Peptides | Asprosin in umbilical cord of newborns and maternal blood of gestational diabetes, preeclampsia, severe preeclampsia, intrauterine growth retardation and … |
| Annals of Nutrition and Metabolism | Serum Asprosin Concentrations Are Increased and Associated with Insulin Resistance in Children with Obesity Pubmed: 31775140 |
| Endokrynologia Polska | Investigation of plasma asprosin and saliva levels in newly diagnosed type 2 diabetes mellitus patients treated with metformin Pubmed: 32944923 |
| International Journal of Endocrinology | Serum Levels of Asprosin, a Novel Adipokine, Are Significantly Lowered in Patients with Acromegaly 33414826 |
| Naunyn Schmiedebergs Arch Pharmacol | Asprosin, a Novel Therapeutic Candidate for Painful Neuropathy: An Experimental Study in Mice 34985531 |
| Gen Comp Endocrinol | Asprosin modulates testicular functions during ageing in mice Pubmed:35413306 |
| Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
| RPA332Hu01 | Recombinant Asprosin (Asp) | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA332Hu01 | Polyclonal Antibody to Asprosin (Asp) | WB; IHC; ICC; IP. |
| MEA332Hu | Mini Samples ELISA Kit for Asprosin (Asp) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SEA332Hu | ELISA Kit for Asprosin (Asp) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA332Hu | Multiplex Assay Kit for Asprosin (Asp) ,etc. by FLIA (Flow Luminescence Immunoassay) | FLIA Kit for Antigen Detection. |